Torous, V. F., Rangachari, D., Gallant, B. P., Shea, M., Costa, D. B., & VanderLaan, P. A. (2018). PD-L1 testing using the clone 22C3 pharmDx kit for selection of patients with non–small cell lung cancer to receive immune checkpoint inhibitor therapy: Are cytology cell blocks a viable option? J Am Soc Cytopathol.

Torous, Vanda F., Deepa Rangachari, Benjamin P. Gallant, Meghan Shea, Daniel B. Costa, e Paul A. VanderLaan. "PD-L1 Testing Using the Clone 22C3 PharmDx Kit for Selection of Patients With Non–small Cell Lung Cancer to Receive Immune Checkpoint Inhibitor Therapy: Are Cytology Cell Blocks a Viable Option?" J Am Soc Cytopathol 2018.

Torous, Vanda F., et al. "PD-L1 Testing Using the Clone 22C3 PharmDx Kit for Selection of Patients With Non–small Cell Lung Cancer to Receive Immune Checkpoint Inhibitor Therapy: Are Cytology Cell Blocks a Viable Option?" J Am Soc Cytopathol 2018.